Aspen Grove Capital’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$659K Hold
125,000
– – 0.09% 92
2026
Q1
$523K Hold
125,000
– – 0.1% 97
2025
Q4
$601K Hold
125,000
– – 0.1% 89
2025
Q3
$633K Hold
125,000
– – 0.11% 84
2025
Q2
$504K Hold
125,000
– – 0.09% 110
2025
Q1
$341K Hold
125,000
– – 0.07% 144
2024
Q4
$531K Hold
125,000
– – 0.11% 100
2024
Q3
$368K Hold
125,000
– – 0.08% 126
2024
Q2
$435K Hold
125,000
– – 0.1% 115
2024
Q1
$356K Hold
125,000
– – 0.1% 124
2023
Q4
$441K Hold
125,000
– – 0.13% 95
2023
Q3
$324K Hold
125,000
– – 0.12% 112
2023
Q2
$493K Hold
125,000
– – 0.16% 114
2023
Q1
$423K Hold
125,000
– – 0.18% 96
2022
Q4
$448K Buy
+125,000
New +$534K 0.21% 87

Other funds holding SRTA

Aspen Grove Capital's SRTA Position: Q2 2026 in Review

Aspen Grove Capital held its Strata Critical Medical Inc (SRTA) position steady in Q2 2026 at 125,000 shares worth $659K. The position accounts for 0.09% of the portfolio, ranked #92.

Aspen Grove Capital first reported a position in SRTA in Q4 2022 and has held it in 15 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Aspen Grove Capital held 125,000 shares of Strata Critical Medical Inc worth $659K as of Q2 2026.
  • Aspen Grove Capital left its Strata Critical Medical Inc share count unchanged in Q2 2026.
  • Strata Critical Medical Inc made up 0.09% of Aspen Grove Capital's portfolio in Q2 2026, its #92 holding.
  • Aspen Grove Capital first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 15 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.